Viking Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Viking Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 54.34 Sell
20-day SMA: 52.87 Sell
50-day SMA: 58.05 Sell
200-day SMA: 42.26 Buy
8-day EMA: 52.82 Sell
20-day EMA: 53.7 Sell
50-day EMA: 56.82 Sell
200-day EMA: 46.82 Buy

Viking Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.16 Sell
Relative Strength Index (14 RSI): 44.64 Sell
Chaikin Money Flow: 1956002 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.44 - 55.78) Sell
Bollinger Bands (100): (54.78 - 77.1) Sell

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Viking Therapeutics Stock

Is Viking Therapeutics Stock a Buy?

VKTX Technical Analysis vs Fundamental Analysis

Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy or a Sell?

Viking Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Viking Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Viking Therapeutics (VKTX) is a Buy

Viking Therapeutics Share Price Forecast

Is Viking Therapeutics Stock a Buy?

  • Viking Therapeutics share price is 51.71 while VKTX 8-day exponential moving average is 52.82, which is a Sell signal.
  • The stock price of VKTX is 51.71 while Viking Therapeutics 20-day EMA is 53.70, which makes it a Sell.
  • Viking Therapeutics 50-day exponential moving average is 56.82 while VKTX share price is 51.71, making it a Sell technically.
  • VKTX stock price is 51.71 and Viking Therapeutics 200-day simple moving average is 46.82, creating a Buy signal.

Fundamental Analysis of Viking Therapeutics

Is Viking Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

Technical Analysis of Viking Therapeutics

Should I short Viking Therapeutics stock?

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.